Prospective observational cohort (n=80) evaluating continuous intravenous ketamine infusion (0.5 mg/kg/day) plus magnesium sulfate (1000 mg/day) over 4 days for chronic pain.
Prospective observational cohort (80 participants) assessing continuous IV ketamine 0.5 mg/kg/day combined with magnesium sulfate 1000 mg/day administered over four days in hospital for chronic pain.
Evaluations scheduled at day 15, 30 and 60 with outcomes focused on pain reduction and safety/tolerability assessments.
Continuous IV ketamine 0.5 mg/kg/day for 4 days with magnesium sulfate 1000 mg/day in hospital
4-day continuous infusion, 0.5 mg/kg/day
Magnesium sulfate 1000 mg/day IV (co-administered)